BURLINGTON – Life science giant LabCorp, which earlier this week announced a review of its operations in order to drive more shareholder value, is adding Johnson & Johnson executive Kathryn Wengel to its board.
At the same time LabCorp is expanding the board to 10 members from nine.
Kathryn Wengel (Photo via LabCorp)
The company announced the change early Friday.
Wengel is Executive Vice President and Chief Global Supply Chain Officer at Johnson & Johnson. She will be an independent member.
“I am pleased to welcome a renowned healthcare industry veteran like Kathy to the Labcorp Board,” said Adam Schechter, chairman and CEO of Labcorp. “Kathy brings a wealth of experience managing complex healthcare organizations and developing globally diverse teams. We look forward to benefitting from her unique perspective as the Board works with management to advance Labcorp’s role in healthcare and improving the health and lives of patients around the world. Kathy’s appointment is also aligned with the Labcorp Board’s commitment to bring diverse perspectives to the boardroom that will best position us to deliver for our patients, customers, and shareholders.”
In the announcement, Wengel noted:
“I’ve long admired Labcorp for its innovation, leadership and commitment to patients and their health, as most recently demonstrated by the essential role the Company has played in combatting the COVID-19 pandemic over the last year,” said Wengel. “I’m honored to join Labcorp’s board, and I look forward to working with Adam and the entire Labcorp team to deliver on its important mission and the best interests of patients, clients, and shareholders.”
LabCorp launches corporate review; shares jump to 52-week high
